Syneos Health Releases 2022 Health Trends
Retrieved on:
Tuesday, December 21, 2021
Occupational burnout, GLOBE, The, Organization, Cras, CCO, Proposition, Acceleration, Contract research organization, CEO, LinkedIn, Optimism, Diversity, Government, Nasdaq, Syneos Health, New Year, Equity, DE, Industry, Company, CRO, Patient, Industrial change in occupied Japan, Fine chemical, Pharmaceutical industry, Management, Medicine, Renewable energy, Risk management
MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for Industry Change Agents.
Key Points:
- MORRISVILLE, N.C., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released 2022 Health Trends: Insights for Industry Change Agents.
- Simplifying the complex for patients, care providers, scientists, customers and every employee is essential, said Alistair Macdonald, CEO, Syneos Health.
- Subscribe to our podcast for further coverage of the 2022 Health Trends and implications for biopharmaceutical companies in the new year.
- Follow Syneos Health on LinkedIn where our leaders will share their perspectives on these trends.